Dare Bioscience Inc Cash Flow-to-Debt Ratio
Dare Bioscience Inc cash flow-to-debt ratio. Dare Bioscience Inc (DARE) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of $1.44 Million could theoretically repay 0% of its total liabilities ($29.63 Million) in one year. Check DARE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Dare Bioscience Inc (2011–2025)
Cash flow-to-debt ratio of Dare Bioscience Inc from 2011 to 2025. Historical debt coverage capacity for Dare Bioscience Inc across 15 annual periods. Check cash flow reinvestment rate of Dare Bioscience Inc to assess the company's total reinvestment commitment from operating cash flow.
Dare Bioscience Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
Dare Bioscience Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Dare Bioscience Inc. For the full cash flow conversion analysis, see DARE cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -333.62x | $-9.89 Billion | $29.63 Million | ▼ -173974.0% |
| 2024 | 0.19x | $5.39 Million | $28.11 Million | ▲ +113.0% |
| 2023 | -1.48x | $-38.86 Million | $26.33 Million | ▼ -166.9% |
| 2022 | -0.55x | $-18.09 Million | $32.71 Million | ▲ +67.2% |
| 2021 | -1.69x | $-28.76 Million | $17.05 Million | ▲ +41.8% |
| 2020 | -2.90x | $-25.23 Million | $8.70 Million | ▼ -52.5% |
| 2019 | -1.90x | $-13.32 Million | $7.00 Million | ▲ +79.6% |
| 2018 | -9.33x | $-10.27 Million | $1.10 Million | ▼ -255.1% |
| 2017 | -2.63x | $-2.54 Million | $967.04K | ▼ -92.5% |
| 2016 | -1.36x | $-33.54 Million | $24.58 Million | ▼ -26.1% |
| 2015 | -1.08x | $-31.91 Million | $29.48 Million | ▲ +54.2% |
| 2014 | -2.36x | $-19.06 Million | $8.07 Million | ▼ -36.7% |
| 2013 | -1.73x | $-16.61 Million | $9.62 Million | ▼ -703.7% |
| 2012 | -0.21x | $-21.00 Million | $97.70 Million | ▲ +94.5% |
| 2011 | -3.89x | $-16.88 Million | $4.34 Million | — |